The COVID-19 pandemic persists with the emergence of the Nimbus variant, responsible for around 43% of new cases as of mid-June. Nimbus, believed to have enhanced transmissibility, may bind to human cells more effectively than Delta and Omicron. Its symptoms largely mirror previous variants, but a particularly severe sore throat has been noted. As summer approaches, an increase in COVID cases is anticipated due to travel, warranting caution in crowded settings and proactive health measures to mitigate risk.
Nimbus has been responsible for about 43% of new COVID cases in mid-June, gaining traction since April and is characterized by its potential increased transmissibility.
Symptomatically, Nimbus presents similar to previous COVID variants with a common sore throat, distinguishable by an intensified "razor blade sore throat" experience.
Expect another summer surge of COVID-19 cases typically associated with increased travel, but awareness and caution are key to managing risks.
While evidence suggests that Nimbus may bind better to human cells, details remain unconfirmed; community caution is advised.
Collection
[
|
...
]